CLINICAL_TRIALS
trial_result
· 2020-05-29
Clinical Trial Update: Cilostazol and Endothelial Progenitor Cell [Phase 4]
Summary
Phase 4 clinical trial update involving cilostazol and endothelial progenitor cells for acute myocardial infarction.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gyeongsang National University Hospital | Conditions: Myocardial Infarction, Acute | Phase 4 | Status: UNKNOWN